Physicist tackles questions of tiny dimensions

por Moran, B
Publicado 2003

MED18/388: Defining the Optimal Framework Required for the Development of Multimedia Web-based Training: The Mater Misericordiae Hospital / Institute of Healthcare Informatics expe...

por Moran, B
Publicado 1999

Systematic review of classification systems for locally recurrent rectal cancer

por Rokan, Z, Simillis, C, Kontovounisios, C, Moran, B J, Tekkis, P, Brown, G
Publicado 2021

Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy

por Tzivanakis, A., Dayal, S. P., Arnold, S. J., Mohamed, F., Cecil, T. D., Venkatasubramaniam, A. K., Moran, B. J.
Publicado 2018

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

por Zahid, A, Clarke, L, Carr, N, Chandrakumaran, K, Tzivanakis, A, Dayal, S, Mohamed, F, Cecil, T, Moran, B J
Publicado 2020

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemo...

por Mirnezami, R, Mehta, A M, Chandrakumaran, K, Cecil, T, Moran, B J, Carr, N, Verwaal, V J, Mohamed, F, Mirnezami, A H
Publicado 2014

Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video‐conference meeting

por Brandl, A., Westbrook, S., Nunn, S., Arbuthnot‐Smith, E., Mulsow, J., Youssef, H., Carr, N., Tzivanakis, A., Dayal, S., Mohamed, F., Moran, B.J., Cecil, T.
Publicado 2020

Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report

por Silva, R., Moran, B., Das, S., Mulligan, N., Doughty, M., Treacy, A., Sheahan, K., Kelly, C.M., Duffy, A.G., Perry, A.S., Brennan, D.J.
Publicado 2022

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)

por Glynne-Jones, R., Hall, M.R., Lopes, A., Pearce, S., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Wasan, H., Moran, B., Melcher, L., West, N.P., Quirke, P., Wong, W.-L., Beare, S., Hava, N., Duggan, M., Harrison, M.
Publicado 2018

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patien...

por Glynne-Jones, R., Hava, N., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Gaya, A., Wasan, H., Moran, B., Melcher, L., MacDonald, A., Osborne, M., Beare, S., Jitlal, M., Lopes, A., Hall, M., West, N., Quirke, P., Wong, Wai-Lup, Harrison, M.
Publicado 2015

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer

por Eustace, A. J., Madden, S. F., Fay, J., Collins, D. M., Kay, E. W., Sheehan, K. M., Furney, S., Moran, B., Fagan, A., Morris, P. G., Teiserskiene, A., Hill, A. D., Grogan, L., Walshe, J. M., Breathnach, O., Power, C., Duke, D., Egan, K., Gallagher, W. M., O’Donovan, N., Crown, J., Toomey, S., Hennessy, B. T.
Publicado 2021